Francisca Dias is currently Post-Doc in the Molecular Oncology and Viral Pathology Group from the IPO-Porto Research Center. She obtained her BSc in Biochemistry (2012), MSc in Oncology (2014) and PhD in Biomedical Sciences (2020), all from the University of Porto. Her PhD project was carried out at IPO-Porto Research Center in collaboration with the Department of Genetics from the University Medical Center of Groningen (UMGC) in the Netherlands. The PhD research was focused on the study of the miRNA and mRNA content from extracellular vesicles (EVs) obtained from the plasma of clear cell Renal Cell Carcinoma (ccRCC) patients with the aim of defining new prognostic biomarkers able of predicting a more aggressive disease. She has authored or co-authored 26 international scientific publications and 4 book chapters (h-index: 8). Until now, she has supervised 2 undergraduate students and co-supervised 8 MSc students. Her current research is focused on the study and characterization of the EVs derived from urological tumors (renal and prostate), more specifically their miRNA content, and how that can be used to design new therapeutic approaches for those types of cancer. Keywords: Renal Cell Carcinoma, Extracellular Vesicles, Biomarkers, microRNAs, TIMPs, SNPs.